Previous Article | Next Article ![]()
Journal of Bacteriology, July 2000, p. 3972-3980, Vol. 182, No. 14
Department of Microbiology and Immunology,
The University of Melbourne, Melbourne, Victoria 3010, Australia
Received 9 January 2000/Accepted 26 April 2000
RepA, the replication initiator protein of the IncB plasmid pMU720,
acts preferentially in cis. The cis activity of
RepA is thought to be mediated by CIS, a 166-bp region of
DNA separating the coding region of repA from the origin of
replication (ori) of pMU720. To investigate the
trans activity of RepA, the repA gene, without
its cognate ori, was cloned on a multicopy plasmid, pSU39.
The ori on which RepA acts was cloned on pAM34, a plasmid whose replicon is inactive without induction by
isopropyl- Miniplasmid pMU720, a derivative of
the large, low-copy-number, conjugative plasmid pMU707, is a member of
incompatibility group B (8). Replication of pMU720 requires
the synthesis of the RepA protein, which is rate limiting for
replication. Analyses of pMU720 and the closely related
IncI1 plasmid ColIb-P9 have shown that expression of
repA is inhibited by a small antisense RNA, RNAI, which
binds to its complementary sequence in the leader region of the
repA mRNA (29, 38). Binding of RNAI to its target in repA mRNA prevents formation of a pseudoknot that
activates translation of the repA mRNA (1-5, 39, 40,
44-46).
Initiation of replication of pMU720 and ColIb-P9 requires the presence
in cis of two DNA sequences, the origin of replication (ori) and CIS; the latter separates the RepA
coding sequence from ori (23, 30, 41).
Members of the I complex (IncB, IncI1, IncI CIS is composed of two domains. The repA-proximal
domain (5'CIS) has strong transcription termination activity
(23, 30) and is thought to be involved in the loading of
RepA onto ori (30). The repA-distal
domain (3'CIS) is a spacer whose function is to place
sequences within ori at an appropriate distance and on the
correct face of the DNA helix vis à vis the
repA-proximal domain of CIS (30). The
RepA protein of pMU720 does not appear to recognize a specific
sequence(s) in CIS, as the CIS of pMU720 can be
replaced by the CIS of both pMU407.1 and pIE545
(30). By contrast, RepA shows sequence specificity for
ori, in that it activates replication at its cognate
ori and the ori of pMU407.1, which shares
conserved sequence motifs with the ori of pMU720 but not the
ori of pIE545 (30).
The Rep protein of the I complex and IncFII plasmids acts in
cis (12, 18, 21, 23-25); i.e., it preferentially
activates the ori of the DNA molecule from which its mRNA
was transcribed. Studies on the IncFII plasmid R1 have shown that this
property of Rep is dependent on the presence of CIS, in its
native position and orientation (18). In this study, we used
a two-plasmid system, in which the ori is provided on one
plasmid and repA is carried on another plasmid, to
investigate the trans activity of RepA of pMU720 in vivo and
the role played by CIS in this activity. We find that (i)
RepA activity in trans is less efficient than activity in
cis, (ii) the presence of CIS, in its native
orientation, immediately upstream of ori has no effect on
the efficiency of replication of the ori plasmid, (iii) the
presence of CIS, in its native orientation, immediately
downstream of the repA coding sequence of the RepA-producing
plasmid reduces the efficiency of replication of the ori
plasmid, (iv) this inhibitory activity of CIS appears to be
sequence specific and involves interaction with the C-terminal amino
acids of RepA, and (v) transcription, from an upstream promoter, into
CIS of the ori plasmid is not required for
initiation of replication in vivo.
Bacterial strains, plasmids and phages.
The following
strains of Escherichia coli K-12 were used in this study.
E. coli JM101 [
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Effect of CIS on Activity in
trans of the Replication Initiator Protein of an IncB
Plasmid
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-D-thiogalactopyranoside (IPTG). Thus, in the
absence of IPTG, replication of the pAM34 derivatives was dependent on
activation of the cloned ori by RepA produced in
trans from the pSU39 derivatives. The effect of
CIS, when present either on the RepA-producing or the
ori plasmid or both, on the efficiency of replication of
the ori plasmid in vivo, was determined. The presence of
CIS, in its native position and orientation, on the
RepA-producing plasmid reduced the efficiency of replication of the
ori plasmid. This inhibitory activity of CIS
was sequence specific and involved interaction with the C-terminal 20 to 37 amino acids of RepA. By contrast, CIS had no effect
when present on the ori plasmid. Initiation of replication
from the ori in trans was independent of
transcription into CIS.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
, IncK, and IncZ) as well as IncL/M and IncFII
plasmids share this physical arrangement of the three genes required
for replication, but the sequences of repA, CIS,
and ori are not conserved in all of these plasmids. Thus,
RepA, CIS, and ori of pMU720 show extensive
homology to the corresponding sequences of ColIb-P9, R64-11, R144-3
(IncI1), R621a (IncI
), and R387 (IncK) but no significant homology to the sequences of pIE545 (IncZ), R1, and R100
(IncFII) (6, 14, 18, 19, 26, 31, 33). The RepA proteins of
pMU720 and the IncL/M plasmid pMU407.1 share ~40% amino acid
identity, the ori sequences of the two plasmids contain
conserved motifs, but their CIS regions show no significant similarity to each other (6, 30).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
(lac-proAB) supE
thi F' (traD36 proA+B+
lacIqZ
M15)] (20) was used
for cloning and propagating M13 derivatives. XL1 Blue MRF'
[
(mcrA)183
(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1
gyrA96 relA1 lac [F' proAB
lacIqZ
M15 Tn10
(Tetr)] (Stratagene) was used to grow M13 derivatives
which had undergone mutagenesis as described by Vandeyar et al.
(42). JP3438 (thr-1 leuB6 thi-1 lacY1 gal-351 supE44
tonA21 hsdR4 rpoB364 recA56) was used for propagating pMU720
derivatives and for all copy number determinations.
TABLE 1.
Plasmids used in this study
Media, enzymes, and chemicals.
The minimal medium used was
half-strength buffer 56 (22) supplemented with 0.2%
glucose, thiamine (10 µg/ml), and necessary growth factors.
Luria-Bertani (LB
[35]) agar containing basic fuchsin (3 µg/ml) was used as indicator medium for
E. coli cells producing chloramphenicol acetyltransferase
(CAT). Cells containing high levels of CAT produce dark red colonies on
this medium, whereas those containing little or no CAT produce light
colonies (32). Enzymes and chemicals of a suitable grade
were purchased commercially and not purified further.
[35S]dATP
S (>1,000 Ci/mmol) for use in sequencing was
obtained from Amersham Corporation. LB-Km-Ap was LB agar supplemented
with kanamycin (20 µg/ml) and ampicillin (50 µg/ml).
Chloramphenicol was used at 10 µg/ml, isopropylthiogalactoside (IPTG)
was used at 1 mM, and
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (X-Gal)
was used at 25 µg/ml.
Recombinant DNA techniques.
Plasmid and bacteriophage DNA
were isolated and manipulated as described by Sambrook et al.
(35). DNA was sequenced using a model 373 DNA sequencer and
ABI Big Dye Terminator kits (Perkin-Elmer Corporation) or by the method
of Sanger et al. (36), modified in that T7 DNA polymerase
was used instead of the Klenow fragment and terminated chains were
uniformly labeled with [35S]dATP
S.
Oligonucleotide-directed in vitro mutagenesis reactions were performed
on single-stranded M13 templates by the method of Vandeyar et al.
(42). Oligonucleotides were purchased from Bresatec Ltd. or
Gibco BRL. DNA sequencing was used to screen for and confirm the
presence of mutations.
Construction of repA chimeras. The coding sequence of the repA gene of the IncL/M plasmid pMU604 (repAL) was amplified to contain a unique BglII site at the 5' end (at codon 10) and a HindIII site at the 3' end, just downstream of the stop codon. The amplified fragment was inserted into the BglII/HindIII site of M13tg130BS, and its sequence was determined to ensure that it was free of errors. An error-free clone was used as the template for oligonucleotide-directed mutagenesis, which created unique SphI and SalI sites, at positions corresponding to where these sites occur in the coding sequence of the repA gene of the IncB plasmid pMU720. Creation of these two sites did not change the amino acid sequence of RepAL. RepAB-RepAL chimeras were constructed by exchanging corresponding fragments of the two repA genes. Thus, RepABLL-producing plasmid was made by joining the BglII/SphI fragment of pMU720 to the SphI/HindIII fragment of pMU604, whereas RepABLB plasmid was made by joining the BglI/SphI fragment of pMU720, the SphI/SalI fragment of pMU604 and the SalI/HindIII fragment of pMU720. RepAK/RepAB chimeras were generated by replacing the BamHI/SphI fragment of pMU720 by the BamHI/SphI fragment of the IncK plasmid pMU2209. This resulted in replacement of the IncB rnaI gene, the promoter-proximal sequence of repA (and thus the target of RNAI), and the sequence coding for the first 99 amino acids of RepA, by the corresponding sequences of the IncK plasmid.
Construction of RepA plasmids. RepA plasmids were derived from pSU39 by insertion of the repA gene of pMU720, with or without the CIS sequence, into the multiple cloning site. These plasmids do not carry the ori of pMU720, so that the RepA protein they produce is freely available to drive the replication of the ori plasmid present in trans. Expression of repA in the RepA plasmids is derepressed due to the presence of promoter down mutations in the rnaI gene. Mutations were introduced by replacing the pMU720 sequences by those being tested.
Construction of ori plasmids. The ori plasmids were derivatives of pMU1599 (30) in which the IncB replicon has been inactivated by deletion or mutation of repA. Those plasmids that contain repA have had their BamHI/SphI fragment, which carries the rnaI gene and the target for RNAI, replaced by corresponding fragment from the IncK replicon. Since RNAI of the IncK plasmid (RNAIK) does not recognize the target of RNAIB, this exchange ensured that expression of repA on the ori plasmid was regulated at the wild-type level, but expression of repA from the RepA plasmid present in trans remained derepressed. The ori plasmids contain the replicon from pAM34 (13), a modified pMB1 replicon in which the essential preprimer RNA is transcribed from the lacZ promoter operator. Since these plasmids contain the lacIq gene, replication of their pAM34 replicon requires the presence of a lac inducer, such as IPTG. Thus, in the absence of IPTG, replication of the ori plasmids is dependent on the RepA provided in trans by the RepA plasmids. The presence of a CAT reporter gene (derived from pACYC184) allows estimations of the copy numbers of ori plasmids to be made.
Introduction of ori and RepA plasmids into E. coli cells. ori and RepA plasmids were cotransformed into E. coli K-12 strain JP3438 by the method of Chung et al. (10). Cells were plated onto medium containing half-strength buffer 56 (22), 0.2% glucose, 0.2% Casamino Acids, thiamine (10 µg/ml), ampicillin, chloramphenicol, and kanamycin, with and without IPTG, and incubated for 72 h at 37°C. Plates were checked after 48 and 72 h of incubation, and the number and size of colonies produced in the presence and absence of IPTG were compared. Single colonies from plates without IPTG were used for copy number estimations.
Measurement of CAT activity. CAT activity of mid-log-phase cultures, grown in minimal medium containing 0.4% glucose, thiamine, leucine, threonine, kanamycin, ampicillin, and chloramphenicol, was assayed as described by Shaw (37). Cells were disrupted by sonication in a Braun Labsonic 2000 Sonicator and cellular debris removed by centrifugation before use in assays. Each assay was performed at least six times. CAT activity was expressed as units per milligram of protein.
Protein assay. The concentration of protein in cleared cell lysates was determined by the method of Bradford (9), using bovine serum albumin as a standard.
Determination of plasmid copy number. The copy number of ori plasmids was estimated by comparing CAT activity of cells carrying these plasmids to activity of cells carrying pMU1598. pMU1598 had been shown to have a copy number of ~20 (30). The formula used was (CAT activity of ori plasmid)/CAT activity of pMU1598 × 20.
| |
RESULTS |
|---|
|
|
|---|
Does the presence of CIS affect the ability of
ori to be activated by RepA provided in
trans?
In pMU720, CIS is thought to
facilitate the loading of RepA onto the ori (30).
To determine whether CIS also performs this function when
RepA is provided in trans, a two-plasmid system was
developed. RepA was produced from a multicopy (~20 copies per
E. coli chromosomal equivalent) plasmid pSU39 (7)
carrying an intact repA gene, so that both the transcription
and the translation of repA mRNA were driven by its native
sequences. Synthesis of RepA was modulated by the introduction of
promoter down mutations into the gene for the antisense RNA, RNAI
(43). The three mutations used changed the
10 box of the
rnaI promoter from TATACT to TgTACT (RNAI.1), TgTgCT (RNAI.2), and TgTgCg
(RNAI.3), causing progressive decrease in expression of
rnaI and a corresponding increase in expression of
repA (43). Expression of repA is fully
derepressed in the RNAI.3 mutant (43, 45). Since RepA acts
preferentially in cis, the RepA-producing plasmids were
constructed so that they did not carry their cognate, active
ori sequences, which might trap RepA protein and make it
unavailable to activate replication of the ori plasmid in
trans. The ori plasmids were derivatives of
pAM34, which carries a fully repressible pMB1 replicon (13). This replicon is inactive in the absence of an inducer but can be
switched on by the addition of IPTG. The ori sequences were inserted immediately downstream of a transcription terminator, to
ensure that transcription from the
-lactamase gene, which is located
upstream of the site of insertion, did not read through into
ori. The ori plasmids carry a gene encoding a
constitutively expressed CAT, which was used to monitor the plasmid
copy number. All tests were carried out by cotransforming E. coli K-12 strain JP3438 with the ori and RepA plasmids
and selecting for both plasmids, in the presence and absence of IPTG.
CAT assays were carried out on transformants selected and grown in the
absence of IPTG. RepA-ori plasmid combinations, which
produced colonies only in the presence of IPTG, were scored as unable
to activate replication of the ori plasmid in
trans.
|
Does 3'CIS play a role in reducing the
trans activity of RepA?
In the intact IncB replicon,
where RepA activates the ori present in cis, the
3'CIS acts as a spacer for appropriately positioning 5'CIS and ori with respect to each other and can
be replaced by an unrelated sequence of the same length without any
loss in activity (30). Since this role should be superfluous
when CIS is carried on a RepA-producing plasmid that has no
cognate ori, we determined whether the presence of
3'CISB had any effect on the ability of RepA to
activate ori in trans. Deletion of
3'CISB from the RepA-producing plasmid resulted
in the loss of the inhibitory activity seen with the intact
CISB (Fig. 2).
Moreover, replacement of 3'CIS by the same spacer fragment (Km55) that was its fully functional substitute in
cis (30) did not restore the inhibitory activity
of CIS. Insertion of a 63-bp spacer (Km63)
between repA coding sequence and the intact CIS
had no effect on the trans activity of RepA (Fig. 2). By
contrast, this insertion resulted in a three- to sixfold reduction in
the copy number of the intact IncB replicon (30). Insertion
of 5'CISB or the trpA transcription
terminator, immediately downstream of the repA coding
sequence of the RepA-producing plasmid, appeared to result in the
runaway replication of the oriB plasmid, as no
transformants could be detected even on the induction of the pAM34
replicon. Since both trpA terminator and
5'CISB produced the same effect, it is most
likely due to prevention of read-through transcription from
repA into the p15A replicon of the RepA plasmid. If, as
seems likely, such read-through has a deleterious effect on the
replication of the RepA plasmid, then obviation of this effect by
efficient termination of repA transcripts would be expected
to increase or stabilize the copy number of this plasmid and thus lead
to an increase in the level of RepA available to the ori
plasmid. Since the frequency of replication of the
oriB plasmid in the presence of RepA plasmid
that lacks CISB was already so high as to
produce tiny, segregationally unstable colonies, even a small increase
in this frequency might be expected to lead to runaway replication.
|
Characterization of sequences involved in reducing the
trans activity of RepA.
In the IncB replicon,
CIS (CISB) could be replaced by the
corresponding sequences from pMU407.1 (CISL) and
pIE545 (CISZ), with only slight loss of
function (30). However, replacement of
CISB in the RepA-producing plasmid, by either
CISL or CISZ, resulted in
almost complete loss of inhibition of the trans activity of
RepA (Fig. 3), suggesting that this
effect is a result of sequence-specific interactions between RepA and
CIS. To investigate this interaction further, the
repA gene on the RepA-producing plasmid was replaced by a
chimeric gene, in which the promoter and promoter-proximal portion of
the coding sequence came from pMU720 and the remainder of the coding
sequence was from pMU407.1. The resulting protein, RepABLL,
is composed of the N-terminal 99 amino acids of RepAB and
the C-terminal 247 amino acids of RepAL.
RepABLL resembles RepAL in that it can activate
oriL present in cis but fails to
activate replication from oriB. The copy
number of the replicon carrying the
repABLL gene is sevenfold lower than
that of the one with repAL-gene (data
not shown). The activity of RepABLL in trans was
reduced 57-fold by CISB and 19-fold by
CISL (Fig. 3), suggesting that this protein,
unlike RepAB, is able to recognize both the CIS
sequences.
|
Does the presence of the repA gene on the ori plasmid increase its ability to respond to RepA produced in trans? It has been suggested that the mRNA for the Rep protein of the IncFIC replicon of plasmid P307, which is closely related to the replicon of pMU720, is required not only for the synthesis of the initiator protein but also to prime initiation of DNA synthesis (16). It was postulated that the repA mRNA is processed at the junction of the RepA coding sequence and CIS-ori, producing a replication primer that is used by the polymerase for initiation of leading-strand synthesis (16). However, as there was no transcription directed towards the ori region of the plasmids used in the assays described above, synthesis of such a primer is not essential for activation of ori in trans. To determine whether transcription of repA mRNA, upstream of ori, enhances its ability to be activated by RepA produced in trans, IncB replicons encoding mutant RepA proteins unable to initiate replication from the ori present in cis were used as ori plasmids. To prevent RNAI (a trans-acting molecule) produced by these replicons from repressing the synthesis of RepA from the RepA-producing plasmid, the DNA fragment encoding their rnaI gene and the promoter-proximal part of their repA gene was replaced by the corresponding fragment from the IncK plasmid, pMU2209. RNAIK does not interact with the repA mRNA of the IncB plasmid pMU720 (31). Exchange of the DNA fragment carrying rnaI resulted also in replacement of the N-terminal 99 amino acids of RepAB by the corresponding sequence from RepAK. However, these two proteins are so similar that only two amino acids are changed by this exchange (30).
All three repA genes used in these experiments differed in their 3' coding sequences. The first gene had the sequence from pMU720, but its termination codon was present 112 bp upstream of the wild-type position (repABdel37). The second gene had the sequence from pMU604 (repAKLL), and the third gene contained the wild-type sequence from pMU720 (repAKLB). Despite these differences, all three ori plasmids replicated with very similar efficiencies, resulting in copy numbers of 45 to 51 and 15 to 18 in the absence and presence, respectively, of CIS on the RepA-producing plasmid (Fig. 4). These copy numbers are significantly lower than those seen when the only pMU720 sequences present on the ori plasmid are CIS and ori and there is no transcription reading into CIS (Fig. 4, compare lines 2 to 4 with line 1). Furthermore, deletion of the coding sequence for the last 121 amino acids of RepA (RepAKB) from the repA gene of the ori plasmid had no significant effect on its copy number. However, deletion of a sequence encompassing the translation initiation region of repA increased the copy number of the ori plasmid to levels similar to those seen with ori alone, regardless of whether all or only part of the coding sequence of RepA was present on the ori plasmid (Fig. 4). These data suggest that transcriptional activity immediately upstream of CIS-ori has no effect on the efficiency of replication of the ori plasmid, but that synthesis of replication-defective RepA from the ori plasmid reduces the copy number of this plasmid. However, the possibility that removal of translational activity had a polar effect on the level of transcription reading into CIS, which contributed to the observed increase in the copy number of the ori plasmids, cannot be discounted.
|
Effects of mutations involving the DnaA box on the copy number of
the ori plasmid.
The ori of pMU720 contains
the sequence 5' TTATCCACA 3', which is a consensus sequence
for a binding site of the DnaA protein (DnaA box). Although this
sequence is not essential for replication of pMU720, its deletion
lowers the copy number of the wild-type plasmid 3-fold and the copy
number of the RNAI.1 mutant 1.6-fold (30). Deletion of the
DnaA box from the ori plasmid reduced its copy number
3.3-fold (Fig. 5). As found with
ori present in cis, deletion of additional 10 bp
inactivated the ori. Insertion of 10 bp immediately
downstream of the DnaA box reduced the copy number of the
ori plasmid 2.4-fold, whereas insertion of 5 bp reduced it
5.5-fold (Fig. 5). These data show that the DnaA box is required for
efficient activation of ori in trans and that its
effectiveness is largely lost when it is moved by as little as one turn
of the DNA helix. Moving the box by half a helical turn had a greater
effect than moving it by a full turn, indicating that it must be
positioned on the correct face of the helix relative to other sequences
within ori.
|
| |
DISCUSSION |
|---|
|
|
|---|
RepA protein of IncB and IncI1 plasmids is cis acting, preferentially activating the origin of replication on the DNA molecule from which its mRNA was transcribed (23-25). We have constructed a two-plasmid system for studying the activity of RepA, when it is present in trans to the ori on which it acts. Using this system, we show that in the absence of a cognate ori in cis, RepA does activate an ori present in trans. However, this activation requires a much higher level of repA expression than activation of ori in cis, confirming that some aspect of the interaction between RepA and the ori in trans is inefficient. The level of repA expression necessary to initiate replication from an ori in trans is unsustainable when the ori is present in cis, as IncB replicons carrying the RNAI.2 mutation cannot be recovered, presumably due to their runaway replication (data not shown).
The presence of CIS, in its native position and orientation, on the RepA-producing plasmid reduced the copy number of the ori plasmid. This effect required the presence of 3'CIS and involved sequence-specific interaction between CIS and the C terminus of RepA. Thus, it is unlike the interaction between RepA and CIS that is proposed to be the first step in the loading of this protein onto the ori in cis (30). These data suggest that CIS has an additional role, which involves the trapping and/or inactivation of the initiator protein. The current model for the control of frequency of replication initiation of IncB and other I-complex plasmids involves translational regulation of the synthesis of RepA. For this system to work satisfactorily, it is necessary for RepA to be synthesized de novo and to be modified during its first round of initiation, so that it is not available for initiation of subsequent rounds of DNA synthesis. The observed interaction between RepA and CIS might ensure that the initiator protein does not participate in more than one round of replication. The finding that this interaction is sequence specific solves the apparent anomaly posed by the observation that the 3'CIS acts as a nonspecific spacer for loading of RepA in cis (30) yet its sequence is very highly conserved in the I-complex plasmids (14, 31). Studies on the replication initiator protein of the IncFII plasmid NR1 also showed that the presence in cis of the CIS-ori region results in an apparent "titration" of the protein (12). Because this effect was lost when the sequence encoding 3'CIS ori was deleted, it was suggested that the "titration" of Rep was the consequence of its binding to ori. Our data show that, at least in the case of RepA of the IncB plasmid and the chimera composed of N-terminal sequence of IncB and C-terminal sequence of IncL/M proteins, the presence of CIS alone is sufficient to reduce the amount of RepA available for activation of ori in trans.
The only sequence required in trans to the RepA-producing plasmid was ori, supporting the notion that in the intact replicon CIS is involved in loading of RepA onto the ori, but not in the initiation of replication. The efficiency of initiation of replication was not influenced by the presence or absence of transcription into the region upstream of ori, indicating that such transcripts are not involved in priming of DNA synthesis. Initiation of replication of IncFII plasmids was also shown to be independent of transcription into the ori region (12, 27).
Synthesis of RepA protein in cis to ori reduced the copy number of the ori plasmid, regardless of whether the protein was competent for replication or not. The finding that all constructs tested, including one missing the 3'CIS and thus predicted to be impaired in the loading of RepA onto ori in cis, showed similar reduced levels of activation by RepA provided in trans indicates that the mechanism responsible for this phenomenon is unlikely to involve competition between cis- and trans-produced RepA for binding sites in ori. This effect was seen even with proteins carrying C-terminal deletions, showing that its cause is different to the interaction that reduced the availability of protein from the RepA-producing plasmid. It has been suggested that loading of RepA in cis might involve bending of DNA to bring ori and the RepA positioned on 5'CIS close together (30). If that is the case, then it is likely that in this closed-configuration ori is less easily accessible to RepA produced in trans.
All I-complex, IncFII, and FIC plasmids examined to date encode a DnaA box at the 5' end of ori (14, 26, 31, 34). Although this box is not part of minimal ori, its deletion or inactivation reduces the efficiency of replication of IncB and IncFII plasmids (28, 30). Deletion of the DnaA box reduced the copy number of the ori plasmid, showing that the efficiency of activation of ori in trans is also dependent on this sequence. Analysis of binding between RepA and ori of the IncB plasmid in vitro showed that the protein binds immediately downstream of the DnaA box (T. Betteridge, J. Praszkier, J. Yang, and A. J. Pittard, unpublished data). Therefore, the finding that moving the DnaA box by one turn of the helix reduced the copy number of the ori plasmid, and that moving the box by half a helical turn reduced it even more, suggests cooperative interaction between DnaA and RepA. Binding in vitro of DnaA protein to the DnaA box located at the 5' end of the ori of the IncFII plasmid R1 required the presence of RepA, which is indicative of cooperative interaction between the two proteins (17).
The use of a repressible replicon as delivery vector for ori allowed us to distinguish between RepA-ori combinations that resulted in lack of replication of the ori plasmid and those that led to too high a level of replication. Thus, dependence of cotransformation of E. coli cells by ori and RepA plasmids on induction of the repressible replicon was a clear indication of failure of replication by the ori plasmid. On the other hand, the inability to detect cotransformants in both the presence and absence of the inducer was taken as evidence of high level of uncontrolled replication by the ori plasmid. This view was supported by the finding that RepA-ori combinations in which the ori plasmids replicated with high copy number formed small colonies, both in the presence and in the absence of the inducer. Replacement of the oriB by oriL, which has been shown to reduce the copy number of the IncB replicon (30), led to an increase in the size of the colonies and a reduction in the copy number of the ori plasmid. Similarly, although cotransformation of E. coli cells by oriB and RepA-producing plasmids carrying 5'CIS failed, replacement of oriB by oriL or deletion of the C-terminal amino acids of RepA led to high efficiency of transformation. Analysis of these transformants showed that the ori plasmid was replicating with high efficiency, reaching a copy number of ~50 to 60 per chromosomal equivalent (Fig. 2 and 3). In the intact IncB replicon, upward fluctuations in copy number result in increased gene dosage of rnaI. The consequent increase in the concentration of the antisense RNA, RNAI, leads to inhibition of synthesis of RepA, and thus a decrease in frequency of initiation of replication. This feedback loop is missing in our two-plasmid system, because expression of repA from the RepA-producing plasmid is not sensitive to fluctuations in the copy number of the ori plasmid. Consequently, efficient activation of ori in trans may lead to runaway replication of the ori plasmid.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by a grant from the National Health and Medical Research Council.
We thank Iain Wilson for providing del20 and del37 mutants of repA, and we thank Thu Betteridge for excellent technical assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Royal Parade, Victoria 3010, Australia. Phone: 61 3 9344 5679. Fax: 61 3 9347 1540. E-mail: aj.pittard{at}microbiology.unimelb.edu.au.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Asano, K.,
A. Kato,
H. Moriwaki,
C. Hama,
K. Shiba, and K. Mizobuchi.
1991.
Positive and negative regulations of plasmid ColIb-P9 repZ gene expression at the translational level.
J. Biol. Chem.
266:3774-3781 |
| 2. |
Asano, K., and K. Mizobuchi.
1998.
Copy number control of IncI plasmid ColIb-P9 by competition between pseudoknot formation and antisense RNA binding at a specific RNA site.
EMBO J.
17:5201-5213[CrossRef][Medline].
|
| 3. |
Asano, K., and K. Mizobuchi.
1998.
An RNA pseudoknot as the molecular switch for translation of the repZ gene encoding the replication initiator of IncI plasmid ColIb-P9.
J. Biol. Chem.
19:11815-11825.
|
| 4. |
Asano, K.,
H. Moriwaki, and K. Mizobuchi.
1991.
An induced mRNA secondary structure enhances repZ translation in plasmid ColIb-P9.
J. Biol. Chem.
266:24549-24556 |
| 5. | Asano, K., T. Niimi, S. Yokoyama, and K. Mizobuchi. 1998. Structural basis for binding of the plasmid ColIb-P9 antisense Inc RNA to its target RNA with the 5'-rUUGGCG-3' motif in the loop sequence. J. Biol. Chem. 19:11826-11838. |
| 6. |
Athanasopoulos, V.,
J. Praszkier, and A. J. Pittard.
1994.
The replication of an IncL/M plasmid is subject to antisense control.
J. Bacteriol.
177:4730-4741 |
| 7. | Bartolomé, B., Y. Jubete, E. Martínez, and F. de la Cruz. 1991. Construction and properties of a family of pACYC184-derived cloning vectors compatible with pBR322 and its derivatives. Gene 102:75-78[CrossRef][Medline]. |
| 8. | Bird, P. I., and J. Pittard. 1983. Demonstration of a third incompatibility function on plasmids already incompatible with group P and group I plasmids. Plasmid 9:191-200[CrossRef][Medline]. |
| 9. | Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254[CrossRef][Medline]. |
| 10. |
Chung, C. T.,
S. Niemela, and R. H. Miller.
1989.
One step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution.
Proc. Natl. Acad. Sci. USA
86:2172-2175 |
| 11. | Davey, R. B. D., P. I. Bird, S. M. Nikoletti, J. Praszkier, and J. Pittard. 1984. The use of mini-Gal plasmids for the rapid incompatibility grouping of conjugative R plasmids. Plasmid 11:234-242[CrossRef][Medline]. |
| 12. | Dong, X., D. D. Womble, and R. H. Rownd. 1988. In-vivo studies on the cis-acting replication initiator protein of IncFII plasmid NR1. J. Mol. Biol. 202:495-509[CrossRef][Medline]. |
| 13. | Gil, D., and J.-P. Bouché. 1991. ColE1-type vectors with fully repressible replication. Gene 105:17-22[CrossRef][Medline]. |
| 14. |
Hama, C.,
T. Takizawa,
H. Moriwaki,
Y. Urasaki, and K. Mizobuchi.
1990.
Organization of the replication control region of plasmid ColIb-P9.
J. Bacteriol.
172:1983-1991 |
| 15. | Kieny, M. P., R. Lathe, and J. P. Lecocq. 1983. New versatile cloning and sequencing vectors based on bacteriophage M13. Gene 26:91-99[CrossRef][Medline]. |
| 16. |
Maas, R., and C. Wang.
1997.
Role of the RepA1 protein in RepFIC plasmid replication.
J. Bacteriol.
179:2163-2168 |
| 17. |
Masai, H., and K. Arai.
1987.
RepA and DnaA proteins are required for initiation of R1 plasmid replication in vitro and interact with the oriR sequence.
Proc. Natl. Acad. Sci. USA
84:4781-4785 |
| 18. |
Masai, H., and K.-I. Arai.
1988.
RepA protein and oriR-dependent initiation of R1 plasmid replication: identification of a rho-dependent transcription terminator for cis-action of repA protein.
Nucleic Acids Res.
16:6493-6514 |
| 19. |
Masai, H.,
Y. Laziro, and K.-I. Arai.
1983.
Definition of oriR, the minimum DNA segment essential for initiation of R1 plasmid replication in vitro.
Proc. Natl. Acad. Sci. USA
80:6814-6818 |
| 20. | Messing, J. 1983. New M13 vectors for cloning. Methods Enzymol. 101:20-78[Medline]. |
| 21. |
Miki, T.,
A. M. Easton, and R. H. Rownd.
1980.
Cloning of replication, incompatibility, and stability functions of R plasmid NR1.
J. Bacteriol.
141:87-99 |
| 22. |
Monod, J.,
G. Cohen-Bazire, and M. Cohen.
1951.
Sur la biosynthèse de la -galactosidase (lactase) chez Escherichia coli. La specificité de l'induction.
Biochim. Biophys. Acta
7:585-599.
|
| 23. | Mori, A., K. Ito, K. Mizobuchi, and Y. Nakamura. 1995. A transcription terminator signal necessary for plasmid ColIb-P9 replication. Mol. Microbiol. 17:291-301[CrossRef][Medline]. |
| 24. | Murthy, S. 1997. Studies on the cis action of the RepA protein of a group B plasmid of the enteric bacteria. B.Sc. (Honors) thesis. The University of Melbourne, Melbourne, Victoria, Australia. |
| 25. | Nikoletti, S. M. 1986. Molecular studies on incompatibility properties of I complex plasmids. Ph.D. thesis. The University of Melbourne, Melbourne, Victoria, Australia. |
| 26. | Ohtsubo, H., T. B. Ryder, Y. Maeda, K. Armstrong, and E. Ohtsubo. 1986. DNA replication of the resistance plasmid R100 and its control. Adv. Biophys. 21:115-133[CrossRef][Medline]. |
| 27. |
Ortega, S.,
E. Lanka, and R. Diaz.
1986.
The involvement of host replication proteins and of specific origin sequences in the in vitro replication of miniplasmid R1 DNA.
Nucleic Acids Res.
14:4865-4879 |
| 28. |
Ortega-Jiménez, S.,
R. Giraldo-Suárez,
M. E. Fernández-Tresguerres,
A. Berzal-Herranz, and R. Díaz-Orejas.
1992.
DnaA dependent replication of plasmid R1 occurs in the presence of point mutations that disrupt the dnaA box of oriR.
Nucleic Acids Res.
20:2547-2552 |
| 29. |
Praszkier, J.,
P. Bird,
S. Nikoletti, and A. J. Pittard.
1989.
Role of countertranscript RNA in the copy number control system of an IncB miniplasmid.
J. Bacteriol.
171:5056-5064 |
| 30. |
Praszkier, J., and A. J. Pittard.
1999.
Role of CIS in replication of an IncB plasmid.
J. Bacteriol.
181:2765-2722 |
| 31. |
Praszkier, J.,
T. Wei,
K. Siemering, and J. Pittard.
1991.
Comparative analysis of the replication regions of the IncB, IncK, and IncZ plasmids.
J. Bacteriol.
173:2393-2397 |
| 32. |
Proctor, G. N., and R. H. Rownd.
1982.
Rosanilins: indicator dyes for chloramphenicol-resistant enterobacteria containing chloramphenicol acetyltransferase.
J. Bacteriol.
150:1375-1382 |
| 33. | Ryder, T. B., D. B. Davison, J. I. Rosen, E. Ohtsubo, and H. Ohtsubo. 1982. Analysis of plasmid genome evolution based on nucleotide-sequence comparison of two related plasmids of Escherichia coli. Gene 17:299-310[CrossRef][Medline]. |
| 34. |
Saadi, S.,
W. K. Maas,
D. F. Hill, and P. L. Bergquist.
1987.
Nucleotide sequence analysis of RepFIC, a basic replicon present in IncFI plasmids P307 and F, and its relation to the RepA replicon of IncFII plasmids.
J. Bacteriol.
169:1836-1846 |
| 35. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 36. |
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467 |
| 37. | Shaw, V. W. 1975. Chloramphenicol acetyltransferase from chloramphenicol-resistant bacteria. Methods Enzymol. 43:737-755[Medline]. |
| 38. |
Shiba, K., and K. Mizobuchi.
1990.
Posttranscriptional control of plasmid ColIb-P9 repZ gene expression by a small RNA.
J. Bacteriol.
172:1992-1997 |
| 39. |
Siemering, K. R.,
J. Praszkier, and A. J. Pittard.
1993.
Interaction between the antisense and target RNAs involved in the regulation of IncB plasmid replication.
J. Bacteriol.
175:2895-2906 |
| 40. |
Siemering, K. R.,
J. Praszkier, and A. J. Pittard.
1994.
Mechanism of binding of the antisense and target RNAs involved in the regulation of the IncB plasmid replication.
J. Bacteriol.
176:2677-2688 |
| 41. |
Tanaka, K.,
H. Sakai,
Y. Honda,
T. Nakamura,
A. Higashi, and T. Komano.
1992.
Structural and functional features of cis-acting sequences in the basic replicon of plasmid ColIb-P9.
Nucleic Acids Res.
20:2705-2710 |
| 42. | Vandeyar, M. A., M. P. Weiner, C. J. Hutton, and C. A. Batt. 1988. A simple and rapid method for the selection of oligodeoxynucleotide-directed mutants. Gene 65:129-133[CrossRef][Medline]. |
| 43. | Wilson, I. W. 1995. Molecular analysis of the replication control system of IncB plasmids. Ph.D. The University of Melbourne, Melbourne, Victoria, Australia. |
| 44. |
Wilson, I. W.,
J. Praszkier, and A. J. Pittard.
1993.
Mutations affecting pseudoknot control of the replication of B group plasmids.
J. Bacteriol.
175:6476-6483 |
| 45. |
Wilson, I. W.,
J. Praszkier, and A. J. Pittard.
1994.
Molecular analysis of RNAI control of repB translation in IncB plasmids.
J. Bacteriol.
176:6497-6508 |
| 46. |
Wilson, I. W.,
K. R. Siemering,
J. Praszkier, and A. J. Pittard.
1997.
Importance of structural differences between complementary RNA molecules to control of replication of an IncB plasmid.
J. Bacteriol.
179:742-753 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»